Timber Pharmaceuticals, Inc. (TMBR) Social Stream
TIMBER PHARMACEUTICALS INC (TMBR) Price Targets From Analysts
Use the tables below to see what analysts covering TIMBER PHARMACEUTICALS INC think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
Price Target Last Issued August 29, 2022
TMBR Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, TIMBER PHARMACEUTICALS INC's number of analysts covering the stock is higher than nearly none of them.
- In the context of all US stocks, TIMBER PHARMACEUTICALS INC's variance in analysts' estimates is lower than almost 100% of them.
- In terms of how TIMBER PHARMACEUTICALS INC fares relative to Healthcare stocks, note that its average analyst price target is greater than 1.76% of that group.
- TMBR has a greater upside potential (average analyst target price relative to current price) than 273.04% of Healthcare stocks.
What is the outlook for TMBR? Use POWR Ratings for clearer insight into price direction.